ARG63849
anti-Urokinase / uPA antibody
anti-Urokinase / uPA antibody for Western blot and Human
Cancer antibody; Cell Biology and Cellular Response antibody; Metabolism antibody; Neuroscience antibody
1
Overview
Product Description | Goat Polyclonal antibody recognizes Urokinase / uPA |
---|---|
Tested Reactivity | Hu |
Tested Application | WB |
Specificity | This antibody is expected to recognize both reported isoforms. |
Host | Goat |
Clonality | Polyclonal |
Isotype | IgG |
Target Name | Urokinase / uPA |
Antigen Species | Human |
Immunogen | C-HFLPWIRSHTKEEN |
Conjugation | Un-conjugated |
Alternate Names | ATF; uPA; U-plasminogen activator; BDPLT5; EC 3.4.21.73; QPD; URK; Urokinase-type plasminogen activator; u-PA; UPA |
Application Instructions
Application Suggestion |
|
||||
---|---|---|---|---|---|
Application Note | WB: Recommend incubate at RT for 1h. Approx 48 kDa band observed in lysates of human kidney fibroblast cell line HEK293 (calculated MW of 48.5 kDa according to NP_002649.1). A minor band was also consistently observed at appox 35 kDa. This band was successfully blocked by incubation with the immunising peptide, and is consistent with the B chain of Cathepsin B-mediated cleavage product of PLAU (Kobayashi et al, J Biol Chem. 1991 Mar 15;266(8):5147-52; PMID: 1900515). * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. |
Properties
Form | Liquid |
---|---|
Purification | Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. |
Buffer | Tris saline (pH 7.3), 0.02% Sodium azide and 0.5% BSA |
Preservative | 0.02% Sodium azide |
Stabilizer | 0.5% BSA |
Concentration | 0.5 mg/ml |
Storage Instruction | For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. |
Note | For laboratory research only, not for drug, diagnostic or other use. |
Bioinformation
Database Links |
Swiss-port # P00749 Human Urokinase-type plasminogen activator |
---|---|
Gene Symbol | PLAU |
Gene Full Name | plasminogen activator, urokinase |
Background | This gene encodes a serine protease involved in degradation of the extracellular matrix and possibly tumor cell migration and proliferation. A specific polymorphism in this gene may be associated with late-onset Alzheimer's disease and also with decreased affinity for fibrin-binding. This protein converts plasminogen to plasmin by specific cleavage of an Arg-Val bond in plasminogen. Plasmin in turn cleaves this protein at a Lys-Ile bond to form a two-chain derivative in which a single disulfide bond connects the amino-terminal A-chain to the catalytically active, carboxy-terminal B-chain. This two-chain derivative is also called HMW-uPA (high molecular weight uPA). HMW-uPA can be further processed into LMW-uPA (low molecular weight uPA) by cleavage of chain A into a short chain A (A1) and an amino-terminal fragment. LMW-uPA is proteolytically active but does not bind to the uPA receptor. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2009] |
Function | Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin. [UniProt] |
Cellular Localization | Secreted. [UniProt] |
Research Area | Cancer antibody; Cell Biology and Cellular Response antibody; Metabolism antibody; Neuroscience antibody |
Calculated MW | 49 kDa |
PTM | Phosphorylation of Ser-158 and Ser-323 abolishes proadhesive ability but does not interfere with receptor binding. |